6PN-27867-15698 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-06-22
Dose 1 — Moderna
2022-06-24
Registered in v-safe
2022-06-24
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Good · None

Under 3 check-in
2022-06-25
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Fair · Sleepiness, Irritability/crying

Under 3 check-in
2022-06-26
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Fair · Sleepiness, Irritability/crying

Under 3 check-in
2022-06-27
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Fair · Sleepiness, Irritability/crying

Under 3 check-in
2022-06-29
Health check-in — day 7, dose 1, under 3
Feeling: Fair · Sleepiness, Irritability/crying, Loss of appetite, Diarrhea

Under 3 check-in
2022-07-11
Survey response — day 14, dose 1, under 3
MedDRA: Diarrhoea, Fatigue, Injection site erythema, Injection site swelling, Irritability, Pain — Feeling: Fair · Be unable to do your normal daily activities

Free text: Very red swollen injection site (leg). Fatigue, irritability, pain, diarrhea for about 48 hours starting 8 days after injection.

MedDRA releases: 2024-11 · check-in free text available
2022-07-13
Survey response — day 21, dose 1, under 3
MedDRA: Poor quality sleep — Feeling: Fair

Free text: Poor sleep

MedDRA releases: 2024-11 · check-in free text available
2022-07-20
Survey response — day 28, dose 1, under 3
MedDRA: Decreased appetite, Irritability — Feeling: Fair

Free text: Irritable, reduced appetite

MedDRA releases: 2024-11 · check-in free text available
2022-07-27
Dose 2 — Moderna
2022-07-27
Health check-in — day 0, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-07-28
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Fair · Site: Pain, Swelling/hardness · Fever · Sleepiness, Irritability/crying, Loss of appetite

Under 3 check-in
2022-07-29
Survey response — days 1–6 daily, dose 2, under 3
MedDRA: Epistaxis — Feeling: Fair · Site: Pain, Swelling/hardness · Sleepiness, Irritability/crying

Free text: Nosebleed

MedDRA releases: 2024-11 · check-in free text available
2022-07-30
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2022-07-31
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Fair · Irritability/crying

Under 3 check-in
2022-08-01
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Fair · Sleepiness, Irritability/crying, Diarrhea

Under 3 check-in
2022-08-02
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Fair · Diarrhea

Under 3 check-in
2022-08-03
Health check-in — day 7, dose 2, under 3
Feeling: Fair · Irritability/crying, Diarrhea

Under 3 check-in
2022-08-10
Health check-in — day 14, dose 2, under 3
Feeling: Good

Under 3 check-in
2022-08-25
Health check-in — day 28, dose 2, under 3
Feeling: Fair

Under 3 check-in
2022-08-31
Survey response — day 35, dose 2, under 3
MedDRA: Body temperature increased, Cough, Irritability, Oropharyngeal pain, Rhinorrhoea, Somnolence — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Viral symptoms (sore throat, runny nose, cough, sleepiness, irritability, mildly elevated temp (99F)

MedDRA releases: 2024-11 · check-in free text available
2022-09-09
Health check-in — day 42, dose 2, under 3
Feeling: Fair

Under 3 check-in
2022-10-26
Survey response — 3 months, dose 2, under 3
MedDRA: Ear infection, Respiratory syncytial virus infection — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Rsv, ear infection

MedDRA releases: 2024-11 · check-in free text available
2022-10-26
Report sent to call center — 3 months, dose 2, under 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-10-27
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-06-22	Moderna	No
2	2022-07-27	Moderna	No

Call center

Reported	Outcome	VAERS-related outcome
2022-10-26	Unsuccessful

Free text

Release 12 (Under 3) — day 14, dose 1, under 3

2022-07-11

Symptoms: Very red swollen injection site (leg). Fatigue, irritability, pain, diarrhea for about 48 hours starting 8 days after injection.

Release 12 (Under 3) — day 21, dose 1, under 3

2022-07-13

Symptoms: Poor sleep

Release 12 (Under 3) — day 28, dose 1, under 3

2022-07-20

Symptoms: Irritable, reduced appetite

Release 12 (Under 3) — days 1–6 daily, dose 2, under 3

2022-07-29

Systemic reaction (other): Nosebleed

Release 12 (Under 3) — day 35, dose 2, under 3

2022-08-31

Symptoms: Viral symptoms (sore throat, runny nose, cough, sleepiness, irritability, mildly elevated temp (99F)

Release 12 (Under 3) — 3 months, dose 2, under 3

2022-10-26

Symptoms: Rsv, ear infection

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Body temperature increased	·	·	✓
SD	Cough	·	·	✓
SD	Decreased appetite	·	·	✓
SD	Diarrhoea	·	·	✓
SD	Ear infection	·	·	✓
SD	Fatigue	·	·	✓
SD	Injection site erythema	·	·	✓
SD	Injection site swelling	·	·	✓
SD	Irritability	·	·	✓
SD	Oropharyngeal pain	·	·	✓
SD	Pain	·	·	✓
SD	Poor quality sleep	·	·	✓
SD	Respiratory syncytial virus infection	·	·	✓
SD	Rhinorrhoea	·	·	✓
SD	Somnolence	·	·	✓
SRO	Epistaxis	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release